首页> 外文期刊>Journal of Pathology: Journal of the Pathological Society of Great Britain and Ireland >Association of autophagy status with amount of Fusobacterium nucleatum Fusobacterium nucleatum in colorectal cancer
【24h】

Association of autophagy status with amount of Fusobacterium nucleatum Fusobacterium nucleatum in colorectal cancer

机译:自噬地位与核细菌核细菌核癌成核核心成核核心癌的结合癌症

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Fusobacterium nucleatum ( F. nucleatum ), which has been associated with colorectal carcinogenesis, can impair anti‐tumour immunity, and actively invade colon epithelial cells. Considering the critical role of autophagy in host defence against microorganisms, we hypothesised that autophagic activity of tumour cells might influence the amount of F. nucleatum in colorectal cancer tissue. Using 724 rectal and colon cancer cases within the Nurses' Health Study and the Health Professionals Follow‐up Study, we evaluated autophagic activity of tumour cells by immunohistochemical analyses of BECN1 (beclin 1), MAP1LC3 (LC3), and SQSTM1 (p62) expression. We measured the amount of F. nucleatum DNA in tumour tissue by quantitative polymerase chain reaction (PCR). We conducted multivariable ordinal logistic regression analyses to examine the association of tumour BECN1, MAP1LC3, and SQSTM1 expression with the amount of F. nucleatum , adjusting for potential confounders, including microsatellite instability status; CpG island methylator phenotype; long‐interspersed nucleotide element‐1 methylation; and KRAS , BRAF , and PIK3CA mutations. Compared with BECN1‐low cases, BECN1‐intermediate and BECN1‐high cases were associated with lower amounts of F. nucleatum with odds ratios (for a unit increase in three ordinal categories of the amount of F. nucleatum ) of 0.54 (95% confidence interval, 0.29–0.99) and 0.31 (95% confidence interval, 0.16–0.60), respectively ( P trend ??0.001 across ordinal BECN1 categories) . Tumour MAP1LC3 and SQSTM1 levels were not significantly associated with the amount of F. nucleatum ( P trend ??0.06). Tumour BECN1, MAP1LC3, and SQSTM1 levels were not significantly associated with patient survival ( P trend ??0.10). In conclusion, tumour BECN1 expression is inversely associated with the amount of F. nucleatum in colorectal cancer tissue, suggesting a possible role of autophagy in the elimination of invasive microorganisms. ? 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
机译:摘要与结肠直肠癌有关的血栓核(F.核核),可以损害抗肿瘤免疫力,并主动侵入结肠上皮细胞。考虑到自噬在对微生物中的宿主防御中的关键作用,我们假设肿瘤细胞的自噬活性可能影响结肠直肠癌组织中的核心核的量。在护士卫生研究中使用724个直肠和结肠癌病例和卫生专业人员随访研究,我们通过BECN1(BECLIN 1),MAP1LC3(LC3)和SQSTM1(P62)表达的免疫组化分析评估了肿瘤细胞的自噬活性。通过定量聚合酶链式反应(PCR)测量肿瘤组织中的核核DNA的量。我们进行了多变量的序数逻辑回归分析,以检查肿瘤BECN1,MAP1LC3和SQSTM1表达的关联,并用核心核,调整潜在混凝剂,包括微卫星不稳定状态; CpG岛甲基甲苯的表型;长时间的核苷酸元素-1甲基化;和kras,braf和pik3ca突变。与BECN1-LIC病例相比,BECN1中间体和BECN1高病例与较低量的F.核心核与含量比率有关(用于单位增加三个序数类别的F.核核心量)为0.54(95%的信心间隔,0.29-0.99)和0.31(95%置信区间,0.16-0.60)(P趋势Δx≤0.001)。肿瘤图1LC3和SQSTM1水平与F.核核心的量没有显着相关(P趋势?& 0.06)。肿瘤BECN1,MAP1LC3和SQSTM1水平与患者存活率没有显着相关(P趋势?& 0.10)。总之,肿瘤BECN1表达与结直肠癌组织中的核核心核的量与核心子宫内膜的量相反,表明自噬在消除侵袭性微生物中的可能作用。还2019年英国和爱尔兰病理学协会。 John Wiley&amp出版; SONS,LTD.

著录项

  • 来源
  • 作者单位

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Department of NutritionHarvard T.H. Chan School of Public HealthBoston MA USA;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

    Department of SurgeryThe Jikei University School of MedicineTokyo Japan;

    Channing Division of Network Medicine Department of MedicineBrigham and Women's Hospital and;

    Department of NutritionHarvard T.H. Chan School of Public HealthBoston MA USA;

    Department of Medical OncologyDana‐Farber Cancer Institute and Harvard Medical SchoolBoston MA USA;

    Department of Medical OncologyDana‐Farber Cancer Institute and Harvard Medical SchoolBoston MA USA;

    Department of BiostatisticsHarvard T.H. Chan School of Public HealthBoston MA USA;

    Department of Medical OncologyDana‐Farber Cancer Institute and Harvard Medical SchoolBoston MA USA;

    Department of Medical OncologyDana‐Farber Cancer Institute and Harvard Medical SchoolBoston MA USA;

    Clinical and Translational Epidemiology Unit Massachusetts General Hospital and Harvard Medical;

    Yale Cancer CenterNew Haven CT USA;

    Program in MPE Molecular Pathological Epidemiology Department of PathologyBrigham and Women's;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 病理学;
  • 关键词

    Colorectal neoplasms; Immunology; Microbiology; Microbiome; Molecular pathological epidemiology; Tumour microenvironment;

    机译:结肠直肠肿瘤;免疫学;微生物学;微生物组;分子病理流行病学;肿瘤微环境;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号